Ampio Pharmaceuticals, Inc.
AMPEDelisted Apr 4, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411906
Ampio Pharmaceuticals, Inc. was delisted on Apr 4, 2024; its insiders filed their last Form 4 on Jun 13, 2023; 28 institutions reported holding it in 13F filings for Q1 2024, worth $34.2K in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Ampio Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- −16 vs. Q2 2022
- Shares held
- 29.6M
- −738.2K (−2.4%) vs. Q2 2022
- Total value
- $1.77M
- −$3.63M (−67.3%) vs. Q2 2022
- New holders
- 4
- 11 more added
- Sold out
- 20
- 25 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AMPE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $67 |
| Q4 2025 | 2 | $2 |
| Q3 2025 | 3 | $1 |
| Q2 2025 | 3 | $1 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 6 | $13 |
| Q1 2024 | 28 | $34.2K |
| Q4 2023 | 29 | $96.8K |
| Q3 2023 | 26 | $8.44K |
| Q2 2023 | 35 | $98.8K |
| Q1 2023 | 36 | $124.7K |
| Q4 2022 | 34 | $90.8K |
| Q3 2022 | 97 | $1.77M |
| Q2 2022 | 114 | $5.41M |
| Q1 2022 | 129 | $22.8M |
| Q4 2021 | 131 | $33.7M |
| Q3 2021 | 121 | $72.6M |
| Q2 2021 | 128 | $75.4M |
| Q1 2021 | 110 | $51.5M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Ampio Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −394,100−100.0% | Sold out |
| ACT Capital Management, LLC | 0 | $0 | 0.00% | −291,500−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −121,374−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −73,284−100.0% | Sold out |
| Park Avenue Securities LLC | 0 | $0 | 0.00% | −73,600−100.0% | Sold out |
| Transform Wealth, LLC | 0 | $0 | 0.00% | −33,382−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −32,480−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −27,522−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −15,181−100.0% | Sold out |
| Cetera Advisor Networks LLC | 0 | $0 | 0.00% | −21,422−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −17,872−100.0% | Sold out |
| Sawtooth Solutions, LLC | 0 | $0 | 0.00% | −11,076−100.0% | Sold out |
| Hoylecohen, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Focused Wealth Management, Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −1,666−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −608−100.0% | Sold out |
| MUFG Americas Holdings Corp | 0 | $0 | 0.00% | −1,665−100.0% | Sold out |
| NTB Financial Corp | – | – | – | – | Not filed |